Published Jun 30, 2026 | 7:00 AM ⚊ Updated Jun 30, 2026 | 7:00 AM
The amendments alter five provisions of the Clinical Establishments Act.
Synopsis: The Centre has softened enforcement under the Clinical Establishments Act by replacing criminal action for minor procedural lapses with administrative penalties. As hospitals welcome lower compliance burdens, a new review traces how decades of lobbying, resistance and negotiations shaped India’s most contested healthcare regulation and the evolving balance between oversight and autonomy.
For nearly 16 years, the Clinical Establishments (Registration and Regulation) Act, 2010, has sat at the centre of one of India’s longest-running healthcare debates.
Supporters saw it as the country’s first serious attempt to bring minimum standards and accountability to a rapidly expanding private healthcare sector. Many doctors and hospital owners saw something different: another law that increased inspections, paperwork and the possibility of criminal action for procedural lapses.
This week, that balance shifted.
On 22 June, the Union Ministry of Health and Family Welfare notified amendments to the Clinical Establishments Act under the Jan Vishwas (Amendment of Provisions) Act, 2026. The changes do not remove hospitals from regulation or dilute minimum standards. Instead, they change how the law is enforced, replacing criminal action for minor procedural violations with an administrative penalty framework.
The government describes the reforms as part of its wider Jan Vishwas initiative to promote “trust-based governance”, reduce the compliance burden, improve the ease of doing business and ensure “proportionate regulatory enforcement” while continuing to safeguard patient safety and healthcare quality.
At first glance, these appear to be technical amendments. In reality, they represent an important shift in India’s approach to regulating private healthcare.
Also Read: Fertility runway: How women are being prescribed weight-loss drugs before conception
The amendments alter five provisions of the Clinical Establishments Act.
Perhaps the most significant change is the replacement of criminal enforcement with administrative adjudication for minor procedural non-compliances.
Under the amended framework, the word “fine” has been replaced with “penalty” in Sections 40, 43 and 46 of the Act. While the change may appear semantic, it fundamentally alters how violations are handled. Instead of criminal prosecution before a court, procedural violations will now be dealt with through an administrative adjudication process.
The amendments also strengthen Section 41 by expanding the powers of adjudicating authorities. These authorities will hear cases under multiple provisions of the Act, provide hospitals and clinical establishments an opportunity to be heard before penalties are imposed, oversee recovery mechanisms and administer the appeals process.
Another important change appears in Section 44, where the law now introduces graded penalties for companies. Rather than treating every procedural lapse alike, regulators are expected to impose penalties that are proportionate to the nature and seriousness of the violation.
The amendments also formalise procedural safeguards. Hospitals facing action are entitled to a hearing before penalties are imposed, while establishments dissatisfied with an order can challenge it through an appeal mechanism.
In practical terms, the law now distinguishes more clearly between procedural non-compliance and serious violations requiring stronger regulatory intervention.
Importantly, however, the amendments do not change the core obligations imposed by the Clinical Establishments Act.
Hospitals must still register.
Minimum standards remain mandatory.
Regulatory oversight continues.
The Centre has not weakened the law’s objectives. Instead, it has changed the way compliance will be enforced.
Also Read: Young-onset Parkinson’s disease rising in India, often going undiagnosed for years
The amendments form part of the broader Jan Vishwas reforms, through which the Union government has amended 79 Central Acts administered by 23 Ministries and Departments. Within the health sector alone, 35 provisions across five Acts have been modified to replace criminal provisions for relatively minor procedural offences with administrative mechanisms.
According to the Ministry of Health and Family Welfare, the objective is to encourage voluntary compliance, reduce unnecessary litigation and create a more facilitative regulatory environment without compromising public accountability.
The shift reflects a broader change in regulatory philosophy.
Rather than relying primarily on criminal prosecution, the government is signalling that compliance, proportional penalties and administrative resolution should become the first response to minor violations.
For hospitals, the amendments promise fewer criminal consequences for paperwork-related lapses.
For regulators, they create greater flexibility in deciding how different kinds of violations should be addressed.
For patients, however, an obvious question follows.
Does replacing criminal action with administrative penalties merely reduce unnecessary compliance burdens, or does it also alter the balance between hospital autonomy and public accountability?
That question is hardly new.
Long before the Jan Vishwas reforms, the Clinical Establishments Act had become one of India’s most fiercely contested health laws, drawing resistance from sections of the medical profession, support from patient rights advocates and repeated debates over how far the government should regulate private healthcare.
A newly published review in the Oxford journal Health Policy and Planning suggests those battles were never simply about registration or inspections.
Reviewing 37 studies spanning nearly five decades, the authors conclude that the Indian Medical Association (IMA) has been “successful in influencing, stalling or limiting legislation” across several areas of health policy.
“The IMA has developed interrelated interior and exterior strategies to shape health policy,” the authors write, arguing that the association’s influence extends from participation in government committees to litigation, strikes and public campaigns.
The Clinical Establishments Act stands out as one of the clearest examples of that long-running struggle.
To understand why the Centre’s latest amendments matter, it is necessary to revisit the political and professional battles that have shaped the Act since it first became law.
Also Read: The human body has limits. Climate change is testing them on the playing field
When the Clinical Establishments Act came into force in 2010, it was presented as a landmark effort to bring uniform standards to India’s fragmented healthcare system.
The idea was straightforward. Hospitals and clinics would register with authorities, comply with minimum standards and become part of a transparent regulatory framework. Patients would have greater assurance about the facilities where they sought treatment, while governments would gain a mechanism to monitor quality across an increasingly privatised healthcare sector.
But the law immediately exposed a deeper disagreement over how India’s private healthcare system should be regulated.
The review published in Health Policy and Planning argues that the debate was never simply about registration requirements or paperwork. Instead, it reflected competing ideas about the role of the state, the autonomy of doctors and the regulation of private medical practice.
“The IMA has been successful in influencing, stalling or limiting legislation,” the authors write, concluding that the association has repeatedly shaped health policy through both formal participation and public mobilisation.
The Clinical Establishments Act became one of the clearest illustrations of that influence.
One of the review’s more interesting findings is that the IMA did not rely on a single strategy.
Instead, the authors describe two complementary approaches: “interior” and “exterior” strategies.
The first involved working from within.
The IMA participated in expert committees, consulted with ministries and secured representation on drafting bodies responsible for shaping health legislation. According to the review, this gave the association opportunities to influence policies before they entered Parliament or state legislatures.
The second strategy unfolded outside government.
When negotiations failed or legislation moved in directions the association opposed, the IMA organised strikes, public campaigns, legal challenges and media outreach.
“The IMA has developed interrelated interior and exterior strategies to shape health policy,” the authors write.
The Clinical Establishments Act witnessed both.
As the legislation evolved, the association raised concerns over compliance requirements, inspection mechanisms and provisions governing private hospitals. Even after the law was enacted, debates continued over its implementation, particularly around standardisation, pricing and regulatory oversight.
The review notes that the IMA also called a nationwide strike in 2012 against aspects of the Act. One study cited by the authors observed that while the strike had limited impact on the legislation itself, it strengthened mobilisation within the profession and reinforced the association’s position as a powerful voice in health policy debates.
Also Read: The suffering nobody counts: How chronic pain is affecting India’s workforce
The review suggests that much of the resistance centred on the way regulation would be implemented rather than on the idea of standards themselves.
For many doctors, particularly owners of small clinics and nursing homes, greater inspection powers raised concerns about bureaucratic harassment.
Several studies reviewed by the authors describe these fears using a familiar phrase in Indian regulatory debates: “inspector raj.”
The concern was that frequent inspections, discretionary enforcement and criminal provisions could become tools for harassment instead of improving patient care.
Those arguments often resonated most strongly with smaller establishments operating with limited administrative staff and resources.
Yet the review also cautions against treating all opposition to regulation as identical.
A small nursing home worried about repeated inspections may have very different concerns from a large corporate hospital facing tighter regulation of billing practices or hospital charges.
Both, however, could find themselves opposing the same legislation through the same professional association.
As the review notes, the IMA’s positions have often reflected “narrowly based” interests in protecting private medical practice and preserving the dominance of biomedicine, even while representing members whose motivations differed considerably.
The Jan Vishwas amendments do not settle the questions that surrounded the Clinical Establishments Act when it was enacted.
Supporters of the reforms argue that replacing criminal prosecution with administrative penalties creates a fairer and more proportionate system, encouraging compliance without exposing hospitals to criminal action for procedural lapses.
Others may ask whether reducing the possibility of criminal prosecution weakens accountability in a sector where patients often have limited bargaining power.
The review does not attempt to answer that policy question.
What it does show is that the debate over hospital regulation has always extended beyond inspections, registration certificates or penalties.
It has been a debate about who should shape India’s healthcare system, how much oversight private providers should face and where the balance should lie between professional autonomy and public accountability.
Seen in that light, the latest amendments represent more than a technical change to a decade-old law.
They are the latest chapter in a conversation that has shaped Indian health policy for years, and one that is unlikely to end with the replacement of a “fine” by a “penalty.”
